Houston Child Receives Bone Marrow Transplant for Cancer
The 7-year-old patient is recovering in the hospital following a donation from her sister to treat her leukemia.
Updated on Oct. 21, 2026 in Cancer

A 7-year-old girl recently underwent a bone marrow transplant at Texas Children's Hospital in Houston to treat acute myeloid leukemia. She remains in the hospital as she continues her recovery and ongoing chemotherapy treatments.
Why it matters
Bone marrow transplants serve as a critical treatment for aggressive blood cancers like acute myeloid leukemia by replacing diseased marrow with healthy cells. This procedure marks a significant milestone in the patient's long-term care plan, which requires extended medical supervision.
The clinical course for this 7-year-old patient involves a bone marrow transplant followed by an expected one-month hospital stay. The effectiveness of this procedure in achieving remission for acute myeloid leukemia remains under observation as she continues further rounds of chemotherapy.
The players
Alison Plaza
A 7-year-old patient currently receiving care for acute myeloid leukemia.
Emma Plaza
The sibling and bone marrow donor for the patient.
Texas Children's Hospital
A Houston-based medical center specializing in pediatric care and oncology treatments.
The details
The bone marrow transplant involved harvesting healthy marrow from the patient's sister, Emma Plaza, to replace the child's own bone marrow affected by leukemia. Following the procedure, the patient requires a controlled hospital environment to manage immune system reconstitution and prevent complications. She is currently undergoing a multi-month chemotherapy regimen to support the success of the transplant and eliminate remaining cancer cells.
Timeline
July 2026: The patient was diagnosed with acute myeloid leukemia.
August 2026: The family transitioned to living at the hospital.
October 2026: The patient and her sister underwent bone marrow transplant surgery.
Health Landscape
This procedure follows the established standard-of-care pathways for pediatric blood cancers outlined by major pediatric oncology institutions. The focus remains on leveraging sibling donors to improve engraftment success rates in young patients with acute myeloid leukemia.
Families facing a pediatric leukemia diagnosis should consult with their oncology team about the necessity and eligibility requirements for bone marrow transplants. Understanding the duration of intensive care settings is vital for planning the logistical and emotional needs of the household.
The takeaway
Bone marrow transplants represent a life-saving intervention in the treatment arc for acute myeloid leukemia. Families dealing with similar diagnoses should work closely with their hematology specialists to understand the full timeline of post-transplant recovery and necessary ongoing chemotherapy.
Further reading
For more on the standard approaches for blood cancer care, visit our Cancer resources.
Source note: This article includes information reported by Kwtx.









